Azithromycin has a tissue half-life of approximately 68 hours and a serum half-life of 68 hours, allowing a 3 or 5-day course to provide therapeutic concentrations for 10 days. This pharmacokinetic property is due to:

• A Extensive plasma protein binding that creates a large reservoir
• B Active secretion by renal tubules that prolongs the elimination half-life
• C Enterohepatic recirculation that repeatedly returns the drug to the systemic circulation
• D Extensive tissue distribution and high intracellular accumulation (Vd ~31 L/kg), with slow release from cells ✓

Explanation

Azithromycin has an extraordinarily large volume of distribution (Vd approximately 31 L/kg in adults), reflecting massive accumulation in tissues and intracellular compartments, particularly within phagocytes (macrophages, neutrophils) — concentrations at sites of infection can be 10-100 times higher than serum levels. Once distributed, the drug is slowly released from tissues back into plasma, resulting in a prolonged tissue half-life. This property allows once-daily dosing and short-course regimens while maintaining adequate concentrations at infection sites throughout a typical 10-day antibiotic course. It also explains why serum concentrations measured during or after a course may not reflect tissue concentrations.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.